Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Non Operating Income: 2012-2025

Historic Non Operating Income for Sunshine Biopharma (SBFM) over the last 11 years, with Sep 2025 value amounting to $65,355.

  • Sunshine Biopharma's Non Operating Income fell 47.20% to $65,355 in Q3 2025 from the same period last year, while for Sep 2025 it was -$33,399, marking a year-over-year decrease of 104.17%. This contributed to the annual value of $443,147 for FY2024, which is 34.29% down from last year.
  • Per Sunshine Biopharma's latest filing, its Non Operating Income stood at $65,355 for Q3 2025, which was down 12.46% from $74,655 recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Non Operating Income ranged from a high of $946,747 in Q4 2021 and a low of -$4.9 million during Q1 2021.
  • Its 3-year average for Non Operating Income is $118,953, with a median of $123,767 in 2024.
  • Per our database at Business Quant, Sunshine Biopharma's Non Operating Income slumped by 8,580.13% in 2021 and then surged by 1,442.82% in 2023.
  • Sunshine Biopharma's Non Operating Income (Quarterly) stood at $946,747 in 2021, then tumbled by 91.06% to $84,599 in 2022, then soared by 86.13% to $157,464 in 2023, then plummeted by 258.28% to -$249,227 in 2024, then plummeted by 47.20% to $65,355 in 2025.
  • Its Non Operating Income stands at $65,355 for Q3 2025, versus $74,655 for Q2 2025 and $75,818 for Q1 2025.